Corporate Tech Investors

Ionis Pharmaceuticals

Ionis Pharmaceuticals is a corporate VC investing group that partners with companies that are a good strategic fit.

Venture Investor Overview

Contact Information

Background Information

Overview

Ionis Pharmaceuticals, Inc. is a leading drug discovery and development company, focused exclusively on the therapeutic target, RNA. Founded in 1989, Isis' mission is to develop products from its RNA-based technologies, such as antisense. Very little was known about antisense when the Company was first established, but its founders envisioned an opportunity to revolutionize the pharmaceutical industry with a more efficient and targeted means of drug discovery. Since then, Isis scientists have made tremendous progress advancing the science of antisense, unveiling capabilities that have far exceeded their expectations.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

1/6/2021

Transaction History

Our records indicate that Ionis Pharmaceuticals invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

Stanley Crook

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Ionis Pharmaceuticals has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Browse more corporate investors:

IONIQ | IPGL

Share this article

About Our Database of Corporate Tech Investors

This corporate tech investor profile is powered by VentureDeal.com, a leading supplier of corporate VC funding data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary